Biochemical responses of healthy subjects during dietary supplementation with L-arginine

Journal of Nutritional Biochemistry

Volumn 15, Issue 9, 2004, Pages 534-539

  Evans, Rhobert W ^a   Fernstrom, John D ^b   Thompson, Julie ^c   Morris Jr , Sidney M ^b   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Ionics Instruments   (United States)

Author keywords

Asymmetric dimethy L arginine; Human; L arginine; Supplements; Symmetric dimethy L arginine; Total nitrates

Indexed keywords

ARGININE; CITRULLINE; CREATININE; CYCLIC GMP; GLUCOSE; GLYCINE; LYSINE; METHYL GROUP; NITRATE; ORNITHINE;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SCREENING; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOCONCENTRATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RECORDING; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ARGININE; BIOLOGICAL AVAILABILITY; BLOOD; BLOOD GLUCOSE; CITRULLINE; CYCLIC GMP; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCINE; HUMANS; INSULIN; LYSINE; MALE; ORNITHINE;

EID: 4444321443     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2004.03.005     Document Type: Article

References (35)

1. Moncada S., Palmer R.M.J., Higgs E.A. Biosynthesis of nitric oxide from L-arginine. Biochem Pharmacology. 38:1989;1709-1715
2. Böger R.H., Bode-Böger S.M. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 42:2001;79-99
3. Ignarro L.J. Nitric oxide. Biology and pathobiology. 2000;Academic Press, San Diego
4. Visek W.J. Arginine needs, physiological state and usual diets A reevaluation. J Nutr. 116:1986;36-46
5. Wu G., Morris S.M. Jr. Arginine metabolism nitric oxide and beyond. Biochem. J. 336:1998;1-17
6. Beaumier L., Castillo L., Yu Y.-M., Ajami A.M., Young V.R. Arginine New and exciting developments for an "old" amino acid. Biomed Environ Sci. 9:1996;296-315
7. Wu G. Synthesis of citrulline and arginine from proline in enterocytes of postnatal pigs. Am J Physiol. 272:(Gastrointest Liver Physiol 35):1997;G1382-G1390
8. Barbul A. Arginine Biochemistry, physiology, and therapeutic implications. J Parenter Enter Nutr. 10:1986;227-238
9. Flynn N.E., Meininger C.J., Haynes T.E., Wu G. The metabolic basis of arginine nutrition and pharmacotherapy. Biomed Pharmacother. 56:2002;427-438
10. Cyonber L. Immune-enhancing diets for stressed patients with special emphasis on arginine content Analysis of the analysis. Curr Opin Clin Nutr Metab Care. 6:2003;189-193
11. Griffith O.W., Stuehr D.J. Nitric oxide synthases Properties and catalytic mechanism. Annu Rev Physiol. 57:1995;707-736
12. Forstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath I., Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 23:1994;1121-1131
13. Kurz S., Harrison D.G. Insulin and the arginine paradox. J Clin Invest. 99:1997;369-370
14. Tsikas D., Boger R.H., Sandmann J., Bode-Boger S.M., Frolich J.C. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett. 478:2000;1-3
15. Pettersson A., Uggla L., Backman V. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr. 692:1997;257-262
16. Heinegard D., Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 43:1973;305-310
17. Bondar R.J.L., Mead D.C. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 20:1974;586-590
18. Tangphao O., Grossman M., Chalon S., Hoffman B.B., Terrence F. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol. 47:1999;261-266
19. Reyes A.A., Karl I.E., Klahr S. Role of arginine in health and in renal disease. Am J Physiol. 267:1994;F331-F346
20. Luiking Y.C., Weusten B.L.A.M., Portincasa P., Van Der Meer R., Smout A.J.M.P., Akkermans L.M.A. Effects of long term oral L-arginine on esophageal motility and gallbladder dynamics in healthy humans. Am J Phys. 274:1998;G984-G991
21. Barbul A., Lazarou S.A., Efron D.T., Wasserkrug H.L., Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery. 108:1990;331-337
22. Clarkson P., Adams M.R., Powe A.J., Donald A.E., McCredle R., Robinson J., McCarthy S.N., Keech A., Celermajer D.S., Deanfield J.E. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 97:1996;1989-1994
23. Chin-Dusting J.P.F., Kaye D.M., Lefkovits J., Wong J., Bergin P., Jennings G.L. Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol. 27:1996;1207-1213
24. Lerman A., Burnett J.C. Jr, Higano St, McKinley L.J., Holmes D.R. Jr. Long term L-arginine supplementation improves small vessel coronary endothelial function in humans. Circulation. 97:1998;2123-2128
25. Herlitz H., Jungersten L.U., Wikstrand J., Widgren B.R. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension. Kidney Int. 56:1999;1838-1845
26. Beaumier L., Castillo L., Ajami A.M., Young V.R. Urea cycle intermediate kinetics and nitrate excretion at normal and "therapeutic" intakes of arginine in humans. Am J Physiol. 269:1995;E884-E896
27. Theilmeier G., Chan J.R., Zalpour C., Anderson B., Wang B.Y., Wolf A., Tsao P.S., Cooke J.P. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine. Arter Thromb Vasc Biol. 17:1997;3557-3564
28. Baylis C., Vallance P. Measurement of nitrite and nitrate levels in plasma and urine - what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens. 7:1998;59-62
29. Boger R.H., Bode-Boger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., Blaschke T.F., Cooke J.P. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 98:1998;1842-1847
30. Bode-Boger S.M., Boger R.H., Kienke S., Junker W., Frölich J.C. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Comm. 219:1996;598-603
31. G-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol. 8:1997;1437-1442
32. Fleck C., Janz A., Schweitzer F., Karge E., Schwertefeger M., Stein G. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int. 59:2001;S14-S18
33. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric synthesis in chronic renal failure. Lancet. 339:1992;572-575
34. Floyd J.C. Jr, Fajans S.S., Conn J.W., Knopf R.F., Rull J. Insulin secretion in response to protein ingestion. J Clin Invest. 45:1966;1479-1486
35. Floyd J.C. Jr, Fajans S.S., Conn J.L.S., Knopf R.F., Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 45:1966;1487-1502